[ad_1]
On December 26, Greece will receive the first small batch of Pfizer / Biontech vaccines for the coronavirus that will amount to 9,750 doses as announced by the Secretary General of Primary Health Care, Marios Themistokleous.
The next day, the first vaccinations will be carried out in Attica’s reference hospitals (Evangelismos, Sotiria, Attiko, Thriasio, Asklipieio Voulas) so that they can start the vaccinations of their medical staff.
On the 28th, the doses of the vaccines will be distributed at the Larissa University Hospital, the AHEPA, the University Hospital of Ioannina and Patras, so the vaccines will begin for your health personnel on December 29.
On December 30, except unexpectedly, Greece will receive the first large batch of 83,850-dose vaccines. Deliveries corresponding to our population based on the definitive agreement must have received 429,000 installments at the end of January and another 333,450 installments at the end of February.
By the end of March, Greece will have received 1,265,000 shares from Pfizer / Biontech alone. The Moderna and AstraZeneca deliveries are expected to be added in January once approved.
According to the schedule, vaccinations in the general population are expected to begin within the second ten days of January.
Who will be vaccinated first
As explained by the president of the National Vaccination Committee Maria Theodoridou, with European coordination in the supply of vaccines, availability will be gradual and therefore each member country makes its priority in the populations that will be vaccinated.
There are no significant differences from state to state and prioritization is based on risk of severe illness or death or constant exposure to the virus.
In Greece, the first group to be vaccinated are “front-line combatants, health workers,” emphasized Ms Theodoridou, noting that they have more than twice the risk of the rest of the population.
Older people will continue in structures such as homes for the elderly or chronically ill and people with other problems.
The next to be vaccinated are those over 85 years of age.
Ms Theodoridou stressed that even when it is time to get vaccinated, “the problem is not over.” He added that this is a big step but one that needs attention and we must continue to wear masks, keep our distance and keep our hands hygienic.
The three conditions for vaccine approval
Regarding the speed with which coronavirus vaccines were developed, Ms Theodoridou said it is due to the development of biotechnology, the ideal cooperation of many research centers and “rich funding”.
He assured that independent international bodies that evaluate and approve vaccines, such as the FDA, strictly review data and clinical trials and must meet three conditions:
Security, that is to say, have no side effects.
Immunogenicity, that is, increase the antibodies that protect the individual.
EffectivenessIn other words, offering protection to the vaccinated person against exposure to the disease.
The Pfizer / Biontech vaccine, according to Ms Theodoridou, shows that it has great safety, the side effects are similar to those seen in regular vaccines, creates a high antibody titer even in old age and its effectiveness exceeds 94 %.
Source: skai.gr
